Oral Bisphosphonates and Risk of Atrial Fibrillation and Flutter in Women: A Self-Controlled Case-Series Safety Analysis

BACKGROUND: A recent trial unexpectedly reported that atrial fibrillation, when defined as serious, occurred more often in participants randomized to an annual infusion of the relatively new parenteral bisphosphonate, zoledronic acid, than among those given placebo, but had limited power. Two subseq...

Descripción completa

Detalles Bibliográficos
Autores principales: Grosso, Anthony, Douglas, Ian, Hingorani, Aroon, MacAllister, Raymond, Smeeth, Liam
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2648983/
https://www.ncbi.nlm.nih.gov/pubmed/19266096
http://dx.doi.org/10.1371/journal.pone.0004720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2648983/
https://www.ncbi.nlm.nih.gov/pubmed/19266096
http://dx.doi.org/10.1371/journal.pone.0004720

Ejemplares similares